遗传易感性假说

更新于 2026年11月19日 版权声明
五、遗传易感性假说

大量研究一致显示,PSD与脑卒中后神经功能缺损程度密切相关,其相关性甚至超过病变部位与PSD的关联,随着时间的延长,神经功能缺损程度对PSD 的预测价值比病灶部位更大。另外,PSD 也与既往重症抑郁史、神经质性格、认知损害、生活事件、社会支持不足等因素相关,这些既是PSD 社会心理学机制的支持证据,同时也是抑郁症与PSD 共同的易感危险因素,提示PSD患者也可能存在与抑郁症相关的遗传易感因素;PSD可被解释为脑卒中事件触发了易感个体发生了抑郁症,同时功能残疾、生活事件、社会支持不足等因素作为应激因素促发了PSD[32,33]。因此,PSD遗传易感性研究围绕抑郁症遗传相关基因开展,有较多证据支持的是单胺类神经递质代谢通路相关基因及海马神经元可塑性相关基因。部分研究提示,5-羟色胺转运体基因启动子区多态性(5-羟色胺TLPR)与PSD相关,携带S等位基因及S/S基因型的人更容易患PSD,也有部分学者持相反意见[33,34]。BDNF是神经营养家族的重要成员,对神经元的生长、分化、存活及损伤后修复有重要的作用,BDNF基因是抑郁障碍的易感基因,BDNF基因的Val66Met 变异导致含有MetBDNF 的囊泡不能正确加工和到达神经树突细胞的突触,从而引起中枢BDNF 的低表达,影响神经元的功能,导致抑郁发生。Met基因是否为抑郁易感基因,目前结论还不一致。有关BDNF基因Val66Met多态性与PSD研究较少,Kohen等[35]和Kim等[36]在韩国人群研究显示,BDNF基因Val66Met多态性与PSD相关,且与5-羟色胺R2A基因多态性存在相互作用。另外,围绕细胞炎症因子、5-羟色胺代谢有关基因与PSD 的遗传易感性也有报道,但研究极少。对PSD 遗传易感性的研究有助于早期预测、识别PSD高危人群并进行预防。

PSD病因复杂,不是单纯生物学或心理学因素的结果,而是上述多种因素共同作用的结果。对遗传易感个体,脑卒中病灶破坏了神经调节通路的化学结构,导致神经递质功能失常,引起神经重塑、炎症反应等变化;突如其来的脑卒中及神经功能障碍作为严重的应激因素,引发了相应的神经内分泌免疫细胞因子网络功能紊乱,促发神经重塑、炎症反应、神经递质代谢紊乱等与PSD发病相关的病理生理改变。在整个PSD发病过程中,这些因素相互作用,因此深入了解PSD发病中各种致病因素的相互作用和相对贡献,有助于更好地预防和治疗PSD。

参考文献

[1]Robinson RG,Spalletta G.Poststroke depression:A Review[J].Can J Psychiatry,2010,55(6):341-349.

[2]Rashid N,Clarke C,Rogish M.Post-stroke depression and expressed emotion[J].Brain Inj,2013,27(2):223-238.

[3]Tirschwell DL,Mitchell PH.Stroke:understanding and easing the burden of poststroke depression[J].Nat Rev Neurol,2011,7(1):12-13.

[4]Hecht D.The neural basis of optimism and pessimism[J].Exp Neurobiol,2013,22(3):173-199.

[5]Drevets WC,Price JL,Furey ML.Brain structural and functional abnormalities in mood disorders:implications for neurocircuitry models of depression[J].Brain Struct Funct,2008,213(1/2):93-118.

[6]Robinson RG,Starr LB,Lipsey JR,et al.A two year longitudinal study of post-stroke mood disorders:dynamic changes in associated variables over the first six months of follow-up[J].Stroke,1984,15(3):510-517.

[7]Singh A,Black SE,Herrmann N,et al.Functional and neuroanatomic correlation in poststroke depression:the sunnrybrook stroke study[J].Stroke,2000,31(3):637-644.

[8]Nys GM,van Zandvoort MJ,van der Worp HB,et al.Early depressive symptoms after stroke:neuropsychological correlates and lesion characteristics[J].J Neurol Sci,2005,228(1):27-33.

[9]Murakami T,Hama S,Yamashita H,et al.Neuroanatomic pathways associated with poststroke affective and apathetic depression[J].Am J Geriatr Psychiatry,2013,21(9):840-847.

[10]Bhogal SK,Teasell R,Foley N,et al.Lesion location and poststroke depression:systematic review of the methodological limitations in the literature[J].Stroke,2004,35(3):794-802.

[11]Tang WK,Lu JY,Chen YK,et al.Association of frontal subcortical circuits infarcts in poststroke depression:a magnetic resonance imaging study of 591 Chinese patients with ischemic stroke[J].J Geriatr Psychiatry Neurol,2011,24(1):44-49.

[12]Zhang T,Jing X,Zhao X,et al.A prospective cohort study of lesion location and its relation to post-stroke depression among Chinese patients[J].J Affect Disord,2012,136(1/2):e83-e87.

[13]Tang WK,Chen YK,Liang H,et al.Cerebral microbleeds as a predictor of 1-year outcome of poststroke depression[J].Stroke,2014,45(1):77-81.

[14]Xekardaki A,Santos M,Hof P,et al.Neuropathological substrates and structural changes in late - life depression:the impact of vascular burden[J].Neuropathol,2012,124(4):453-464.

[15]Santos M,K vari E,Gold G,et al.The neuroanatomical model of poststroke depression:towards a change of focus[J].J Neurol Sci,2009,283(1/2):158-162.

[16]Loubinoux I,Kronenberg G,Endres M,et al.Post-stroke depression:mechanisms,translation and therapy[J].J Cell Mol Med,2012,16(9):1961-1969.

[17]Hayley S, Litteljohn D.Neuroplasticity and the next wave of antidepressant strategies[J].Front Cell Neurosci,2013,7:218.(https://www.daowen.com)

[18]Kronenberg G,Balkaya M,Prinz V,et al.Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression[J].Biol Psychiatry,2012,72(4):273-281.

[19]Bewernick BH,Hurlemann R,Matusch A,et al.Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment resistant depression[J].Biol Psychiatry,2010,67(2):110-116.

[20]Scheidegger M,Walter M,Lehmann M,et al.Ketamine decreases resting state functional network connectivity in healthy subjects:implications for antidepressant drug action[J].PLoS One,2012,7(9):e44799.

[21]Wang X,Li YH,Li MH,et al.Glutamate level detection by magnetic resonance spectroscopy in patients with post - stroke depression[J].Eur Arch Psychiatry Clin Neurosci,2012,262(1):33-38.

[22]Catena-Dell'Osso M,Bellantuono C,Consoli G,et al.Inflammatory and neurodegenerative pathways in depression:a new avenue for antidepressant development[J].Curr Med Chem,2011,18(2):245-255.

[23]Spalletta G,Bossù P,Ciaramella A,et al.The etiology of poststroke depression:a review of the literature and a new hypothesis involving inflammatory cytokines[J].Mol Psychiatry,2006,11(11):984-991.

[24]Maes M,Leonard BE,Myint AM,et al.The new‘5-HT’hypothesis of depression:cell-mediated immune activation induces indoleamine 2,3-dioxygenase,which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs),both of which contribute to the onset of depression[J].Prog Neuropsychopharmacol Biol Psychiatry,2011,35(3):702-721.

[25]Craft TK,DeVries AC.Role of IL-1 in poststroke depressive-like behavior in mice[J].Biol Psychiatry,2006,60(8):812-818.

[26]Su JA,Chou SY,Tsai CS,et al.Cytokine changes in the pathophysiology of poststroke depression[J].Gen Hosp Psychiatry,2012,34(1):35-39.

[27]Spalding KL,Bergmann O,Alkass K,et al.Dynamics of hippocampal neurogenesis in adult humans[J].Cell,2013,153(6):1219-1227.

[28]Arnone D,McKie S,Elliott R,et al.State - dependent changes in hippocampal grey matter in depression[J].Mol Psychiatry,2013,18(12):1265-1272.

[29]Zhang ZH,Wu LN,Song JG,et al.Correlations between cognitive impairment and brain derived neurotrophic factor expression in the hip-pocampus of post-stroke depression rats[J].Mol Med Rep,2012,6(4):889-893.

[30]Masi G,Brovedani P.The hippocampus,neurotrophic factors and depression:possible implications for the pharmacotherapy of depression[J].CNS Drugs,2011,25(11):913-931.

[31]Sheline YI,Barch DM,Price JL,et al.The default mode network and selfreferential processes in depression[J].Proc Natl Acad Sci U S A,2009,106(6):1942-1947.

[32]De Ryck A,Fransen E,Brouns R,et al.Psychosocial problems associated with depression at 18 months poststroke[J].Int J Geriatr Psychiatry,2014,29(2):144-152.

[33]Pearson-Fuhrhop KM,Kleim JA,Cramer SC.Brain plasticity and genetic factors[J].Top Stroke Rehabil,2009,16(4):282-299.

[34]Fang J,Yan W,Jiang GX,et al.Serotonin transporter gene polymorphism in Chinese patients with poststroke depression:a case-control study[J].Stroke,2011,42(5):1461-1463.

[35]Kohen R,Cain KC,Mitchell PH,et al.Association of serotonin transporter gene polymorphisms with poststroke depression[J].Arch Gen Psychiatry,2008,65(11):1296-1302.

[36]Kim JM,Stewart R,Bae KY,et al.Serotonergic and BDNF genes and risk of depression after stroke[J].J Affect Disord,2012,136(3):833-840.

(曹金霞)

✍AI写作